Abstract:We prepared an amphiphilic redox-responsive conjugate based on mPEGylated solanesol, solanesyl poly(ethylene glycol) dithiodipropionate (SPDP), along with its inert counterpart solanesyl poly(ethylene glycol) succinate (SPGS), which self-assembled in aqueous solution to form redox-responsive micelles. Used as efficient drug carriers for doxorubicin (DOX), the micelles acted as synergistic agents for cancer therapy. Dynamic light scattering (DLS) measurements showed that the SPDP micelles had average diameters of 111nm, which decreased to 88nm after the encapsulation of DOX. The mean diameters and size distribution of the disulfide-containing micelles changed obviously in the presence of the reducing agent glutathione (GSH), whereas no changes occurred in the case of redox-insensitive SPGS micelles. DOX could be loaded into both types of micelles, with drug loading content of about 4.0%. A significantly accelerated release of DOX was triggered by GSH for DOX-loaded SPDP micelles, compared with DOX-loaded SPGS micelles. Blank SPGS and SPDP micelles displayed higher inhibition of HeLa and MCF-7 cell proliferation but less cytotoxicity to normal L-02 cells at similar concentrations. Confocal microscopic observation indicated that a greater amount of DOX was delivered into the nuclei of cells following 9 or 12h incubation with DOX-loaded micelles. In vivo studies on H22-bearing Swiss mice demonstrated the superior anticancer activity of DOX-loaded SPDP micelles over free DOX and DOX-loaded SPGS micelles. All of the data presented here suggested that these SPDP micelles may have a dual function, as they are preferentially toxic for tumor cells alone and are efficient and safe carriers for anticancer drugs. Statement of significance: Various nanoscale drug carriers were used to enhance therapeutic effect of many drugs. While, the metabolites of high quantities of carriers may cause additional short- or long-term toxicities. In this study, a new systems based on solanesol derivatives was developed for anticancer drug delivery. There are two features for this system. One is solanesol originated bioactivity of the carrier, which will synergistically facilitate therapeutic effect of the encapsulated drug. The other is the redox-responsive drug release behavior adaptable to the glutathione-rich atmosphere of tumor cell. All the hypothesis have been elucidated in this work through in vitro and in vivo studies. It was found that this drug delivery system may have a dual function, as they are preferentially toxic for tumor cells alone and are efficient and safe carriers for anticancer drugs.

A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles

A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.

Redox Stimuli-Responsive Hollow Mesoporous Silica Nanocarriers for Targeted Drug Delivery in Cancer Therapy

Reduction-Responsive Drug Delivery Based on Mesoporous Silica Nanoparticle Core with Crosslinked Poly(Acrylic Acid) Shell

Synthesis and characterization of a glutathione‐responsive drug delivery system based on aptamer‐coated mesoporous silica

Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles

Ph- and Redox-Triggered Synergistic Controlled Release of a ZnO-gated Hollow Mesoporous Silica Drug Delivery System.

Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity

A Dual-Responsive Drug Delivery System Based on Mesoporous Silica Nanoparticles Covered with Zipper-Type Peptide for Intracellular Transport/release

Redox- and Temperature-Controlled Drug Release from Hollow Mesoporous Silica Nanoparticles.

Construction of a redox-responsive drug delivery system utilizing the volume of AS1411 spatial configuration gating mesoporous silica pores

Redox-responsive mesoporous silica nanoparticles for chemo- photodynamic combination cancer therapy

A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a “tumor-triggered targeting” property

Redox-sensitive polymeric micelles with aggregation-induced emission for bioimaging and delivery of anticancer drugs

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery

Bioresponsive Controlled Drug Release Based on Mesoporous Silica Nanoparticles Coated with Reductively Sheddable Polymer Shell

mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect

Fluorescent Carbon Dot-Gated Multifunctional Mesoporous Silica Nanocarriers for Redox/enzyme Dual-Responsive Targeted and Controlled Drug Delivery and Real-Time Bioimaging.

Photoactive/Passive Molecular Glass Blends: An Efficient Strategy to Optimize Azomaterials for Surface Relief Grating Inscription.

An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery

Redox and Ph Double Stimulus-Responsive Mesoporous Silica Nanoparticles for Drug Delivery